Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:34 PM
Ignite Modification Date:
2025-12-24 @ 5:34 PM
NCT ID:
NCT07106268
Eligibility Criteria:
Inclusion Criteria:
* Cystic or diffuse edema in the macular area, retinal vein tortuous dilation with hemorrhage
* Optical coherence tomography (OCT) examination showed that the macular area was raised, edema and thickened
* Monocular disease, baseline central retinal thickness (CRT) ≥ 250mm
* Intravitreal injection, laser photocoagulation and blood circulation and blood stasis removal drugs were not treated before surgery
* The patient had normal blood pressure, negative urine protein, normal liver and kidney function, and normal electrocardiogram
Exclusion Criteria:
* Patients with fluorescein fundus angiography (FFA) showing a large area (10 optic disc areas) without perfusion requiring retinal photocoagulation
* Patients with chronic dacryocystitis, glaucoma, cataract, severe proliferative vitreoretinopathy or vitreous hemorrhage, epi macular membrane or macular ischemia, diabetic retinopathy, age-related macular degeneration, ocular trauma and other diseases
* Intravitreal therapy or laser photocoagulation with corticosteroids or anti-VEGF drugs within three months before the study
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
80 Years
Study:
NCT07106268
Study Brief:
Protocol Section:
NCT07106268